BostonGene and Daiichi Sankyo are collaborating to integrate AI-driven translational intelligence into an antibody-drug ...

While a cure remains elusive, cancer treatment has seen significant advances in recent years. New innovations include ...

ADCs combine antibodies with drug payloads for targeted therapy, but complex manufacturing requires monitoring CQAs across multiple entities.

Columnist June Casagrande advises readers to ask the internet the right questions when addressing their grammar weaknesses.

Gene therapy holds the promise of preventing and curing disease by manipulating gene expression within a patient's cells. However, to be effective, the new gene must make it into a cell's nucleus. The ...

Q4 2025 Earnings Call February 24, 2026 4:30 PM ESTCompany ParticipantsAndrew Guggenhime - President & CFOGrant Pickering ...

Gene therapy holds the promise of preventing and curing disease by manipulating gene expression within a patient's cells.

NAMkind™ models have now been tested against a wide set of marketed ADC molecules, showing close correlation with clinical results in terms of the toxic impact in the liver and side effect profile in ...

Daiichi Sankyo's upcoming AVANZAR study is critical for the stock, as success would unlock billions in revenue and accelerate ...

To My Shabbat Soul, I owe you an apology. For years you stood at the corner of my week, softly waving, while I sprinted past ...

Drs Kathy Miller and Sunil Badve discuss how HER2 testing has evolved over time as the need for that clinical testing has shifted, including assay limits, biology, and clinical impact.

Under the morning sun, I climb the steep cobblestone streets of the Albaicín. It’s my second day volunteering in music classes at the local primary school. Upon entering Colegio Público Gomez-Moreno, ...